SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-23-083014
Filing Date
2023-11-03
Accepted
2023-11-03 08:31:01
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea187474-s3_protaratherap.htm S-3 346928
2 OPINION OF SULLIVAN & CROMWELL LLP ea187474ex5-1_protaratherap.htm EX-5.1 14887
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea187474ex23-1_protaratherap.htm EX-23.1 2487
4 CALCULATION OF FILING FEE TABLE ea187474ex-fee_protaratherap.htm EX-FILING FEES 76799
5 GRAPHIC image_001.jpg GRAPHIC 6291
  Complete submission text file 0001213900-23-083014.txt   451082
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275290 | Film No.: 231374579
SIC: 2836 Biological Products, (No Diagnostic Substances)